
Nephros NEPH
$ 3.24
-0.46%
Quarterly report 2026-Q1
added 05-07-2026
Nephros Total Inventories 2011-2026 | NEPH
Annual Total Inventories Nephros
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.23 M | 2.62 M | 2.47 M | 3.15 M | 4.46 M | 5.3 M | 2.56 M | 1.86 M | 674 K | 479 K | 591 K | 186 K | 162 K | 312 K | 247 K | 726 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.3 M | 162 K | 1.81 M |
Quarterly Total Inventories Nephros
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.62 M | 2.74 M | 2.24 M | 1.95 M | 2.62 M | 3.1 M | 2.8 M | 2.78 M | 2.47 M | 2.27 M | 2.13 M | 2.35 M | 3.15 M | 3.49 M | 4.66 M | 4.68 M | 4.46 M | 4.65 M | 5.09 M | 4.68 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 2.56 M | 2.56 M | 2.56 M | 2.56 M | 1.86 M | 1.86 M | 1.86 M | 1.86 M | 674 K | 674 K | 674 K | 674 K | 479 K | 479 K | 479 K | 479 K | 591 K | 591 K | 591 K | 591 K | 186 K | 186 K | 186 K | 186 K | 162 K | 162 K | 162 K | 162 K | 312 K | 312 K | 312 K | 312 K | 247 K | 247 K | 247 K | 247 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.3 M | 162 K | 1.92 M |
Total Inventories of other stocks in the Medical instruments industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
82.3 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
846 M | $ 68.2 | -0.61 % | $ 13.6 B | ||
|
Glaukos Corporation
GKOS
|
63.6 M | $ 122.5 | -3.04 % | $ 7.01 B | ||
|
Intuitive Surgical
ISRG
|
1.84 B | $ 417.82 | -2.06 % | $ 149 B | ||
|
ICU Medical
ICUI
|
616 M | $ 143.17 | 0.82 % | $ 3.53 B | ||
|
iRhythm Technologies
IRTC
|
21.6 M | $ 115.19 | 1.19 % | $ 3.69 B | ||
|
Repro Med Systems
KRMD
|
3.68 M | $ 3.97 | -0.74 % | $ 183 M | ||
|
LeMaitre Vascular
LMAT
|
19.6 M | $ 94.48 | -2.18 % | $ 2.14 B | ||
|
Masimo Corporation
MASI
|
459 M | $ 179.95 | - | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
584 K | $ 1.8 | -1.1 % | $ 82.4 M | ||
|
Ekso Bionics Holdings
EKSO
|
4.82 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
3.78 M | $ 0.39 | 1.28 % | $ 32 M | ||
|
Merit Medical Systems
MMSI
|
334 M | $ 67.52 | 0.01 % | $ 3.99 B | ||
|
electroCore
ECOR
|
1.63 M | $ 10.0 | 5.04 % | $ 84.8 K | ||
|
Envista Holdings Corporation
NVST
|
288 M | $ 24.56 | -0.12 % | $ 4.13 B | ||
|
Haemonetics Corporation
HAE
|
306 M | $ 79.53 | 1.04 % | $ 3.75 B | ||
|
Isoray
ISR
|
1.41 M | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
632 M | $ 209.56 | -1.56 % | $ 20.6 B | ||
|
STAAR Surgical Company
STAA
|
15.7 M | $ 29.8 | -0.23 % | $ 1.48 B | ||
|
InfuSystem Holdings
INFU
|
5.39 M | $ 8.88 | -1.66 % | $ 183 M | ||
|
Teleflex Incorporated
TFX
|
404 M | $ 135.45 | -0.22 % | $ 6.04 B | ||
|
Utah Medical Products
UTMD
|
7.94 M | $ 68.56 | 0.72 % | $ 222 M | ||
|
West Pharmaceutical Services
WST
|
444 M | $ 331.45 | -0.96 % | $ 24 B | ||
|
Pulse Biosciences
PLSE
|
136 K | $ 25.2 | -2.21 % | $ 1.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
642 M | $ 10.33 | -1.3 % | $ 2.06 B | ||
|
Retractable Technologies
RVP
|
17.2 M | $ 0.69 | -0.13 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
22.2 M | $ 63.68 | -2.03 % | $ 209 M | ||
|
Predictive Oncology
POAI
|
45.8 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
30.2 M | $ 27.09 | -1.67 % | $ 1.29 B | ||
|
Stereotaxis
STXS
|
9.57 M | $ 1.85 | -0.27 % | $ 168 M | ||
|
Baxter International
BAX
|
2.23 B | $ 20.62 | 2.95 % | $ 10.6 B | ||
|
ResMed
RMD
|
744 M | $ 195.39 | -0.79 % | $ 28.5 B | ||
|
AtriCure
ATRC
|
78.5 M | $ 27.27 | -0.13 % | $ 1.3 B | ||
|
Harvard Bioscience
HBIO
|
20.8 M | $ 6.3 | 4.3 % | $ 280 M | ||
|
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
62 M | $ 12.41 | 0.53 % | $ 507 M | ||
|
Becton, Dickinson and Company
BDX
|
3.89 B | $ 150.4 | -1.08 % | $ 43.3 B | ||
|
OraSure Technologies
OSUR
|
31.1 M | $ 4.12 | -2.95 % | $ 303 M | ||
|
Repligen Corporation
RGEN
|
170 M | $ 133.2 | 2.36 % | $ 7.49 M |